Whole blood interleukin-2 release test to detect and characterize rare circulating gluten-specific T cell responses in coeliac disease.


Journal

Clinical and experimental immunology
ISSN: 1365-2249
Titre abrégé: Clin Exp Immunol
Pays: England
ID NLM: 0057202

Informations de publication

Date de publication:
06 2021
Historique:
revised: 01 01 2021
received: 05 11 2020
accepted: 04 01 2021
pubmed: 21 1 2021
medline: 15 12 2021
entrez: 20 1 2021
Statut: ppublish

Résumé

Whole blood cytokine release assays (CRA) assessing cellular immunity to gluten could simplify the diagnosis and monitoring of coeliac disease (CD). We aimed to determine the effectiveness of electrochemiluminescence CRA to detect responses to immunodominant gliadin peptides. HLA-DQ2·5

Identifiants

pubmed: 33469922
doi: 10.1111/cei.13578
pmc: PMC8119810
doi:

Substances chimiques

Chemokine CXCL10 0
Cytokines 0
Epitopes, T-Lymphocyte 0
HLA-DQ Antigens 0
HLA-DQ2 antigen 0
Interleukin-2 0
Interleukin-8 0
Peptide Fragments 0
Peptides 0
Glutens 8002-80-0
Interferon-gamma 82115-62-6
Gliadin 9007-90-3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

321-334

Subventions

Organisme : ImmusanT, Inc.

Informations de copyright

© 2021 British Society for Immunology.

Références

United European Gastroenterol J. 2014 Aug;2(4):268-78
pubmed: 25083284
United European Gastroenterol J. 2020 Feb;8(1):108-118
pubmed: 32213060
Scand J Immunol. 1994 Jun;39(6):567-74
pubmed: 8009173
Nat Rev Gastroenterol Hepatol. 2018 Oct;15(10):583-584
pubmed: 29973675
Trends Mol Med. 2019 Oct;25(10):836-852
pubmed: 31331739
Nat Med. 2000 Mar;6(3):337-42
pubmed: 10700238
Tissue Antigens. 1998 Nov;52(5):407-15
pubmed: 9864029
Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2831-6
pubmed: 17307878
Gut. 2005 Sep;54(9):1217-23
pubmed: 16099789
Sci Transl Med. 2010 Jul 21;2(41):41ra51
pubmed: 20650871
J Immunol. 2001 Nov 1;167(9):5217-25
pubmed: 11673535
BMC Med. 2020 Nov 26;18(1):362
pubmed: 33239013
J Exp Med. 2002 Mar 4;195(5):643-9
pubmed: 11877487
Aliment Pharmacol Ther. 2020 Jan;51(2):244-252
pubmed: 31769533
Clin Exp Immunol. 2014 Feb;175(2):305-15
pubmed: 24192268
Clin Exp Immunol. 2020 Jan;199(1):68-78
pubmed: 31505020
PLoS One. 2012;7(8):e42340
pubmed: 22879946
Ann Intern Med. 2008 Aug 5;149(3):177-84
pubmed: 18593687
Bioinformatics. 2005 Jun;21 Suppl 1:i29-37
pubmed: 15961469
Gastroenterology. 2018 Mar;154(4):886-896.e6
pubmed: 29146521
Sci Adv. 2019 Aug 07;5(8):eaaw7756
pubmed: 31457091
J Autoimmun. 2015 Jan;56:56-65
pubmed: 25457306
Tuberculosis (Edinb). 2019 Jan;114:91-102
pubmed: 30711163
United European Gastroenterol J. 2019 Dec;7(10):1337-1344
pubmed: 31839959
Immunogenetics. 2020 Feb;72(1-2):85-88
pubmed: 31735991
J Immunol Methods. 2012 May 31;379(1-2):1-14
pubmed: 22370428
J Immunol. 2017 Apr 15;198(8):3005-3014
pubmed: 28373482
Methods. 2006 Apr;38(4):274-82
pubmed: 16473524
Nat Med. 2019 May;25(5):734-737
pubmed: 30911136

Auteurs

R P Anderson (RP)

ImmusanT, Inc., Cambridge, MA, USA.

G Goel (G)

ImmusanT, Inc., Cambridge, MA, USA.

M Y Hardy (MY)

Immunology Division, Department of Medical Biology, The Walter and Eliza Hall Institute, Parkville, VIC, Australia.
University of Melbourne, Parkville, VIC, Australia.

A K Russell (AK)

Immunology Division, Department of Medical Biology, The Walter and Eliza Hall Institute, Parkville, VIC, Australia.
University of Melbourne, Parkville, VIC, Australia.

S Wang (S)

ImmusanT, Inc., Cambridge, MA, USA.

E Szymczak (E)

ImmusanT, Inc., Cambridge, MA, USA.

R Zhang (R)

ImmusanT, Inc., Cambridge, MA, USA.

K E Goldstein (KE)

ImmusanT, Inc., Cambridge, MA, USA.

K Neff (K)

ImmusanT, Inc., Cambridge, MA, USA.

K E Truitt (KE)

ImmusanT, Inc., Cambridge, MA, USA.

L J Williams (LJ)

ImmusanT, Inc., Cambridge, MA, USA.

J L Dzuris (JL)

ImmusanT, Inc., Cambridge, MA, USA.

J A Tye-Din (JA)

Immunology Division, Department of Medical Biology, The Walter and Eliza Hall Institute, Parkville, VIC, Australia.
University of Melbourne, Parkville, VIC, Australia.
Department of Gastroenterology, The Royal Melbourne Hospital, Parkville, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH